As shown in Boston Business Journal, 10 percent of the 100 largest biotech firms in Massachusetts lease space from Cummings Properties.
 
 
Office, laboratory and research space
 

Cummings Properties, a Mass Biotech Council member, leases low-cost office, laboratory, research and tech space in Boston, Somerville, Woburn, Wakefield, Beverly, Medford, Sudbury, and Cambridge, MA. Lease Massachusetts high tech space of any size. Join the dozens of leading biotech, pharmaceutical and medical research firms already relocated from Cambridge and Boston to Cummings' north-suburban LEED-certified campuses. See Boston Globe and Banker and Tradesman stories.

"Staying local" has resulted in Cummings Properties having great in-depth knowledge of Boston’s north-suburban commercial space market. The unique proximity to major highways of most Cummings facilities (almost 10 million square feet in total of inexpensive, award-winning Boston area office, laboratory and production space) affords businesses unparalleled visibility, easy access, and user-friendly business environments. Cummings also offers business incubator space for office and laboratory needs.

One of the company’s strongest assets continues to be its ability to offer very competitively priced and desirable New England space to multitudes of fast growth companies. Tenant firms recognize that the most prime, fertile opportunities for success lie along and around the coveted Route 128 ( I-95) and Interstate 93 corridors, where the vast majority of all Cummings Properties’ facilities are located.

Lease genomics space, proteomics space or nanotechnology space in Massachusetts from New England's most experienced provider. Tech space for lease from 300 to 30,000 square foot units. Lease Boston, Cambridge area space for fuel cell technology and all other tech space needs. Lease contiguous blocks of space up to 300,000 square feet.

Continuing acquisitions have expanded the portfolio to include 78 large or very large properties, consisting of luxurious Massachusetts office space, wide bay assembly buildings, major warehouse properties, and laboratories of all sorts. On the residential side, Cummings has successfully developed upscale single-family subdivisions, luxury condominiums, and two major assisted living facilities. The Cummings geographic base has expanded as well, to include a host of North Shore and Metrowest communities. Cummings leases New England office and research space in Woburn, Medford, Wilmington, Somerville, Cambridge, Boston, Beverly, Burlington, and Sudbury, MA.

Cummings Properties has the ability to customize buildouts to meet almost any tenant requirement. The firm has designed and built hundreds of specialized facilities, including tempest rooms, TV studios, biotech labs, cleanrooms, hospital operating rooms, and complete medical centers, as well as thousands of office, executive office, retail, warehouse, and R&D spaces. The firm also custom-builds brand new Massachusetts buildings for lease.

 
Unusually, Cummings Properties supports its own 18-person in-house design team including six registered architects and engineers. Altogether, there are more than 280 full-time people in Cummings Properties’ year-round management, leasing, operations, and construction groups. Because of the vast depth of staff experience accumulated over more than 30 years, Cummings Properties’ people understand the complex requirements of the most discerning prospective tenants. Cummings Properties staff of Regular Full Time Employees currently have almost 2,000 years of accumulated experience with the firm!

Cummings’ business strategy remains simple: provide the best value and highest degree of service to meet the business needs of almost 1,800 client firms of all sizes. While hundreds of our larger tenants occupy up to a hundred thousand square feet each (or more), The Firm diligently serve hundreds of other firms with only a few hundred square feet using its own Boston, Massachusetts commercial real estate listings!

With such a vast inventory of fully built-out space, Cummings Properties has a constant availability of space from normal turnovers, even though the firm works very hard to retain all existing tenants. And when exactly the right space is not readily available from inventory, it can usually be built out easily within the month if necessary.

Of special interest to growing firms, Cummings’ leasing officers can include Additional Space Guarantees in almost any lease, when requested by expansion-minded firms. The highly flexible nature of most Cummings facilities makes this a very valuable and important tenant option.

Cummings Properties' continuous expansion provides new opportunities and growth space for existing tenants and prospects alike. The Company recently built an entirely speculative 300,000 square foot executive office and research building at Cummings Center in Beverly.

Additionally, the firm has recently completed its most visible signature building -- the 400,000 square foot TradeCenter 128. This highly attractive building, between Exits 34 and 35 in Woburn, is now one of the single-most prominent, and certainly also one of the very finest structures, anywhere along Route 128/I-95. The property is available for lease in increments of greater than 50,000 square feet.

Contact the main Cummings Properties leasing office or Leasing Manager Erica Wright at 781-935-8000 for specific information about filling any office, research, executive office, or other commercial need. Alternatively, contact Steve Drohosky, general manager of Cummings Center in Beverly, Massachusetts about space in that two million square foot complex, at 978-922-9000.

Laboratory, Office and Research Space

Why lease with Cummings Properties?

The process of acquiring ultra low cost, inexpensive Massachusetts office, research or production space is typically one of the very most important decisions most firms make. And beyond the simple cost of the space itself, there are many even more serious considerations which must never be overlooked. The most major of these is the satisfaction, morale and productivity of the people who will occupy the facility.

While there will always be substantial dollars involved in acquiring space, the salaries incurred in actually populating the space are usually far greater by comparison. People who become nonproductive, or whose productivity is restricted because of space they don’t like, are hugely expensive.

Most Cummings Properties low-cost office and research facilities in Massachusetts directly abut major highways or are very close to them. They also tend to be very close to other services or amenities which make utilization of their leased space much easier and more practical. Cummings Park and West Cummings Park in Woburn, MA and Cummings Center in Beverly, MA offer outstanding examples of how many important services and amenities can be incorporated into well-thought-out business parks.

 
 
Cummings Foundation

The large majority of all Cummings Properties' buildings, including all of Cummings Park and West Cummings Park in Woburn, have been donated to, and are operated for the benefit of, Cummings Foundation, Inc. (CFI). Founded in 1986, CFI is an operating foundation, which also owns and operates the not-for-profit New Horizons retirement communities in Massachusetts. Additionally, CFI owns Veterinary School at Tufts, LLC, which it operates in conjunction with Cummings School of Veterinary Medicine at Tufts University. All Cummings buildings in Burlington, Marlborough, Medford, Somerville, Stoneham, Sudbury, Wakefield and Wilmington are owned by the Foundation. See "About us."

 

 

Representative Available Space

Note: Cummings Properties now leases space to more than 2,100 business clients in 78 large multiple occupancy MA office, research, and laboratory buildings throughout greater Boston. With more than 9 million square feet to lease, and so many tenants, there are always many new units opening up every month, and the company virtually always has a fine selection of available spaces either currently or imminently available. All units are offered for lease, however, strictly as illustrative of specific units which might or not be still actually available, even when first viewed on this site. Rates are based on a five-year term, but shorter terms may be accommodated.

Cummings Properties leases tech space of all sorts, and is eager to collaborate and assist with broad, innovative approaches supporting groups of current or prospective client firms in advancing industry technology. Of special interest are initiatives supporting Life Sciences, Nanotechnology and Embedded Systems. Firms of this nature are very prominent in the two major clusters of technology firms developing in both Woburn and Beverly, Massachusetts, particularly in space developed by Cummings Properties.

For information on a recent debriefing from The Hague concerning High Tech Connections (HTC) for Dutch delegates (click here).

New England Regional Biosafety Laboratory

The New England Regional Biosafety Laboratory (NE-RBL) is a 41,000 square foot facility at Cummings School of Veterinary Medicine, dedicated to the study of existing and emerging infectious, diseases, toxin-mediated diseases and medical countermeasures important to biodefense. Scientists within the NE-RBL are conducting research to develop therapeutics, vaccines and diagnostic tools in a safe, secure, regulatory-compliant environment. Information for investigators about research and collaborative possibilities with the Cummings School and the NE-RBL can be found on the Information for Researchers Page.

 

 

All offerings at all times are subject to the possibility of prior leasing to others. No lease may be effective at any time prior to the full execution of the lease by both parties. Prices and availability subject to change without notice.

 

Built out lab suites from 900 SF at Cumings Center, Beverly
 High-tech Client News
Merck picks VisEn Medical for imaging agents
Mass High Tech, March 6, 2007
Life sciences: Pushed or pulled to the suburbs?
Mass High Tech, February 16, 2007
Innov-X lands $27M in new funding
Mass High Tech, January 8, 2007
Boston Life Sciences bids $35M for spinal cord drug license
Mass High Tech, January 4, 2007
VisEn inks Asian distribution deal with Olympus
Mass High Tech, December 11, 2006
 
 
 
 
 
 
 

Cummings Properties, a Mass Biotech Council (MBC) member, is among the state's most alert and aggressive commercial real estate firms in leasing space for life science and other research users in Massachusetts, attracting biotech firms and other major research facilities. Long known as an early haven for start-ups, the 30-year old development firm also hosts major facilities of some of the area's largest and most active biotech firms, and can assist in the permitting process for a variety of applications.

Learn more about our Life Sciences Team, a group of experienced professionals with expertise in the design, construction and financing of lab space, at BIO 2007. We will be at booth A28 in the Massachusetts Pavilion, near the Massachusetts Biotechnology Council booth. Many Cummings clients will be among the thousands of national and international biotech and life sciences pioneers at this major Boston convention.

Cummings leases office and research space in Woburn, Beverly, Medford, Burlington, Lexington, Cambridge, Sudbury, Wakefield, Stoneham and Wilmington, MA. Serving more than 1,700 different client businesses, with a total of more than eight million square feet of first class commercial space. Research businesses are a large part of its recent growth.

Almost two million square feet of the portfolio is currently leased to biotech, meditech and other high tech companies. Among the larger Cummings biotech research and manufacturing tenants are Agencourt Bioscience; Anika Therapeutics; BioProcessors; BioTrove; Center for Blood Research; Incyte Pharmaceuticals; Inotek; Medtronic Vascular Systems; Thermo-Orion Research; U.S. Genomics; and ZymeQuest.

 
Cummings Properties' in-house architectural team has designed most of these high tech facilities. These clients' products extend from pharmaceuticals to prosthetics, and include medical instrumentation, DNA sequencing, and a human tissue bank and the laboratory facilities range from start-up incubator size labs, usually available for immediate, turnkey occupancy, to chemical labs and large-scale pilot plant manufacturing operations ranging to more than 100,000 square feet. Lease any size Massachusetts commercial real estate.

Cummings Properties' in-house capabilities include laboratory planning and design, custom fit-up, financing and complete construction services. Let us design the ideal high tech space for your business. Lease MA biotech or other life sciences research space from a Massachusetts leader.

 

 
Most biotech and other life science firms leasing space from Cummings Properties are certainly not among the largest such firms in the state. Start-up firms are always welcome, and many are already leasing incubator research space. Most are included among the following representative list of current life sciences firms which do lease Cummings buildings in greater Boston.
 
 

Advanced Micro Devices, Inc.
AdvanDx, Inc.
Aegis Semiconductor, Inc.
Agencourt Bioscience Corporation
Agilent Technologies, Inc.
AgION Technologies, L.L.C.
Amphotech, Ltd.
Ancora Pharmaceuticals
Anika Therapeutics, Inc.
Aphios Corporation
AXYA Medical, Inc.
Beckman Coulter, Inc.
Becton, Dickinson & Company (Discovery Labware, Inc.)
Bio Devices
BioMolecular Assays, Inc.
BioProcessors Corporation
Biotek, Inc.
BioTrove, Inc.
Bistech, Inc.
Brontes Technologies
Cambria Biosciences LLC
CBR Laboratories, Inc.
Cell Signaling Technology, Inc.
Clinigen, Inc.
CNH Technologies, Inc.
Creagen Biosciences, Inc.
Cutis Pharma, Inc.
Cybio USA, Inc.
CytoCure, LLC
Cytomatrix, LLC
East Coast Clinical Research, Inc.
Elucida Research, LLC
Eyetech Pharmaceuticals, Inc.
Flexplay Technologies, Inc.
GeneXP Biosciences, Inc.
Globio Corporation
Hamilton Thorne Biosciences, Inc.
Hettich Instruments, L.P.
ImmunoDiagnostics, Inc.
Incyte Corporation
Inotek Pharmaceuticals Corporation
Insulet Corporation
Intercytex Limited
ivpcare, inc.
Lilliputian Systems, Inc.
Linden Technologies, Inc.
Marsh Bio Products, Inc.
Massachusetts State Pharmaceutical Association
Matsushita Electric Works R&D Laboratory, Inc.
Medtronic Interventional Vascular, Inc.
Meiogen Biotechnology Corporation
Mercury Therapeutics, Inc.
Millenium Research Laboratories, Inc.
Modular Genetics, Inc.
Nanobiosym
Nantero, Inc.
Natural Pharmaceuticals, Inc.
Neurological Models, Inc.
New England Biolabs, Inc.
New England P.E.T. Manufacturing & Distribution Center, LLC
Newton Laboratories, Inc.
Northeast Biomedical Research Institute, Inc.
NUCRYST Pharmaceuticals. Inc.
OraChrom, Inc.
Pierce Biotechnology, Inc.
PKC Pharmaceuticals, Inc.
ProScience Analytical Services, Inc.
Proteome Systems, Inc.
Purogen
Repromedix Corporation
Scion Pharmaceuticals, Inc.
Sensitech, Inc.
Smith & Nephew, Inc.
Soltec Ventures, Inc.
SRU Biosystems, LLC
Tecan Boston, Inc.
Thermo Electron Corporation (Orion)
Thermo Lab Systems, Inc.
Thrasos, Inc.
Tissue Regeneration, Inc.
US Genomics, Inc.
Viacor, Inc.
VisEn Medical, Inc.
Waratah Pharmaceuticals, Inc.
Waters Technologies Corporation
ZymeQuest, Inc.

 

Along with the following companies, Cummings Properties is a member of the
Mass Biotech Council:

21st Century Biochemicals
454 Life Sciences
ABBOTT Bioresearch Center
ABCAM, Inc.
ABIOMED, Inc.
Absolute Science, Inc.
Abt Associates Clinical Trials
Acambis, Inc.
Acceleron Pharma, Inc.
Accenture
Accounting Management Solutions, Inc.
Accovion Inc.
ACOM* Healthcare
ActivBiotics
Acusphere, Inc.
Addgene, Inc.
AdipoGenix, Inc.
Adnexus Therapeutics, Inc.
Advanced Cell Technology
Advanced Magnetics, Inc.
Advanced Proteome Therapeutics Inc.
AdvanDx, Inc.
Aeris Therapeutics, Inc.
Aerotek
Agencourt Bioscience Corporation
Agilent
Agrenetics
Alantos Pharmaceuticals Holding, Inc.
Alexandria Real Estate Equities, Inc.
Alkermes, Inc.
Alnylam Pharmaceuticals
ALPCO Diagnostics
ALS Therapy Development Foundation
Althea Technologies, Inc.
Altus Pharmaceuticals Inc.
American Australian
Association of New England
American Integrated Biologics, Inc.
Amgen, Inc.
Ancora Pharmaceuticals
Anika Therapeutics, Inc.
Anthill Technologies, Inc.
Antigen Express, Inc.
Antigenics, Inc.
Aphios Corporation
ApoConsult LLC
Apogee Technology, Inc.
Apple Computer, Inc.
Apredica
Archemix Corporation
Ariad Pharmaceuticals, Inc.
Ariston Pharmaceuticals, Inc.
ArQule, Inc.
Arteriocyte Inc.
Artisan Pharma Inc.
Ascent Therapeutics, Inc.
Associates of Cape Cod, Inc.
AstraZeneca R&D Boston
Athena Diagnostics, Inc.
AVANT Immunotherapeutics, Inc.
Avatar Pharmaceutical Services, Inc.
Avecia Biotechnology, Inc.
AVEO Pharmaceuticals, Inc.
Averion, Inc.
Babson Executive Education
BattelleCRO, Inc.
Baxter Healthcare
BDO Seidman, LLP
Bentley College
Beth Israel Deaconess Medical Center
BG Medicine, Inc.
BIND Biosciences, Inc.
Bingham McCutchen LLP
Bio-Concept Laboratories
Bioactives
bioBridges LLC
Biocair
Biogen Idec
BioHelix Corporation
Biomeasure, Incorporated
Biomedical Research Models
BioPhysics Assay Laboratory, Inc.
BioProcessors Corp.
Biopure Corporation
Bioscience Valuation LLC
BioSquare at Boston University Medical Center
BioTeam Paris Region
Biotricity Medical, Inc.
Biotrofix, Inc.
BioTrove, Inc.
BioVentures Investors
Biovest International, Inc.
BioVex, Inc.
Blue Cross Blue Shield of Massachusetts
Blue Sky Biotech, Inc.
Blue Stream Laboratories
Boston Analytical
Boston Biochem, Inc.
Boston Biomedical Research Institute
Boston Biomedical, Inc.
Boston Life Sciences, Inc.
Boston University
Bowdoin Group
Bristol Community College
Bristol-Myers Squibb Medical Imaging
British Consulate - General
Broad Institute of MIT & Harvard
Bromberg & Sunstein, LLP
Burns & Levinson LLP
Caliper Life Sciences, Inc.
Cambrex Bioscience Hopkinton, Inc.
Cambria Biosciences LLC
Cambridge BioMarketing Group, LLC
Cambridge Biomedical
Career Program
Cambridge Biomedical Research Group, Inc.
Cambrios Technologies Corporation
Canadian Consulate General
Cancer Research Technology Inc.
Capital Advisors Group
Capralogics, Inc.
Cardinal Health
Cardiovascular Clinical Studies, LLC
Cato Research - Boston
CB Richard Ellis/New England
CBR Institute for Biomedical Research
CBSET, Inc.
Cell Essentials, Inc.
Cell NetwoRx LLC
Cell Signaling Technology
CellPoint Diagnostics Inc.
Cequent Pharmaceuticals, Inc.
Certus International, Inc.
Charles River Laboratories
Chemic Laboratories, Inc.
Children's Hospital Boston, Intellectual Property Office
Choate, Hall & Stewart LLP
Chubb Group of Insurance Companies
CIS-US, Inc.
Clarkston Consulting
CleanRooms Magazine
ClinLab Staffing
Clinquest, Inc.
CNH Technologies, Inc.
Codexis, Inc.
Codon Devices
Cogenics
Coley Pharmaceutical Group
Collegium Pharmaceutical
Columbia Insurance Agency, Inc.
CombinatoRx, Inc.
Comerica Bank/Technology & Life Sciences Division
Commonwealth Sciences, Inc.
CompuCyte Corporation
CoNCERT Pharmaceuticals, Inc.
Confluent Surgical, Inc.
CORFO-ASEMBIO
Correlagen, Inc.
Court Square Data Group
Covance Inc.
Craven & Ober, Policy Strategists, LLC
CreaGen Biosciences, Inc.
Critical Therapeutics, Inc.
Cubist Pharmaceuticals, Inc.
Cummings Properties, LLC
Curis, Inc.
Cytel Inc.
Cytomyx, LLC
Cytonome, Inc.
CytRx Laboratories
Cytyc Corporation
D. Glass Associates, Inc.
Dacon Corporation
Dana Farber Cancer Institute
Decision Biomarkers
Decision Resources, Inc.
Deloitte & Touche LLP
DLA Piper US LLP
DNAR Inc.
Dow Biopharmaceutical Contract Manufacturing Services
Dragonfly Sciences, Inc.
Duane Morris LLP
Dyax Corporation
Dynogen Pharmaceuticals, Inc.
EBI Consulting
ECI Biotech, Inc
Economic Development Council of Western Massachusetts
Edwards Angell Palmer & Dodge LLP
Eisai Research Institute of Boston, Inc.
Eli Lilly & Company
Eliassen Group, Inc.
Elixir Pharmaceuticals, Inc.
Elucida Research LLC
Embarc Inc.
EMD Lexigen Research Center Corp.
EMD, Serono, Inc.
ENANTA Pharmaceuticals, Inc.
Endpoint Research LLC
Ensemble Discovery Corporation
EnVivo Pharmaceuticals, Inc.
Enzymatics, Inc.
Epitome Biosystems
EpiVax Inc.
EPIX Pharmaceuticals, Inc.
Equis Corporation
Ernst & Young Global Biotechnology Center
ETEX Corporation
Exact Sciences Corporation
Exalpha Biologicals, Inc
Exiqon, Inc.
Eyegate Pharmaceuticals Inc.
Febit Inc.
Feinstein Kean Healthcare
Fidelity Bioscience Group
Finnegan, Henderson,
Farabow, Garrett & Dunner, LLP
Fish & Richardson P.C.
Flagship Ventures
Fleishman - Hillard
FoldRx Pharmaceuticals
Foley & Lardner LLP
Foley Hoag LLP
Forest City Commercial
Group | Boston Forest City Science + Technology Group
Formatech, Inc.
French Office for Science and Technology
Fresenius Biotech North America, Inc.
Fulcrum Pharma Development Inc.
Fusion Medical Education, LLC
Galenea
Gene - IT, Inc.
Gene Logic Inc.
Genetic Services, Inc.
Genetix Pharmaceuticals, Inc.
Genetix USA Inc.
Genexion, INC
Genfit Corp.
Genocea Biosciences, Inc.
Genstruct, Inc.
Geny Research Group, Inc.
Genzyme Corporation
GFusion, Inc.
GlaxoSmithKline, Inc.
Global Prior Art, Inc.
Gloucester Pharmaceuticals, Inc.
GLSynthesis, Inc.
Goodwin Procter LLP
GPC Biotech Inc.
Greater Boston Chamber of Commerce
Green Mountain Antibodies, Inc.
Greenberg Traurig, LLP
GTC Biotherapeutics, Inc.
GulfStream Bioinformatics Corp.
Gwathmey, Inc.
GZA GeoEnvironmental, Inc.
Harvard Clinical Research Institute (HCRI)
Harvard Extension School
Harvard Medical School
Harvard University
Health Advances, Inc.
Helicos BioSciences Corporation
HireMinds LLC
Histogenics Corporation
Hyaluron Contract Manufacturing
Hydra Biosciences, Inc.
Hypnion, Inc.
I-Therapeutix, Inc.
IBM Corporation
Idenix Pharmaceuticals, Inc.
Idera Pharmaceuticals
IDEXX Laboratories, Inc.
IDIS
iMarc
Immunetics, Inc.
ImmunoGen, Inc.
IMPACT Technology Consultants
Indevus Pharmaceuticals,
Inc.
Indigene
Pharmaceuticals, Inc.
Infinity Pharmaceuticals, Inc.
InnovaPharm, Inc.
Innovation Norway
Inotek Pharmaceuticals Corporation
Integrated Project Management Company, Inc.
Intelligent Bio-Systems, Inc.
Intelligent Medical Devices, Inc.
Intercytex Ltd.
Interleukin Genetics, Inc.
International Biotechnology
Investment Corp.
Intrasphere Technologies, Inc.
Invitrogen Corporation
IQuum, Inc.
J. Calnan & Associates, Inc.
Javelin Pharmaceuticals, Inc.
JETRO (Japan External Trade Organization)
Johnson & Johnson Regenerative Therapeutics
Johnson Matthey Pharma Services
Jones Lang LaSalle
Joule Technical Staffing
K&L Gates
Kard Scientific
Keel Pharmaceuticals
Keystone Partners
Kforce Scientific and Clinical Research Group
KPMG LLP
Krolman Corporation
L.E.K. Consulting LLC
LabPros, Inc.
LaVoie Strategic Communications Group, Inc.
Levin & Company, Inc.
Life Science Insights
Link Medicine Corporation
Living Microsystems Inc.
LNR Property Corporation Northeastern Region
Lonza Biologics, Inc.
Lyme Properties, LLC
Mabbett & Associates, Inc.
MacDougall Biomedical Communications, Inc.
MacroChem Corporation
Magen BioSciences
Makoto Life Sciences, Inc.
MannKind BioPharmaceuticals
Marinus Pharmaceuticals, Inc.
Marsh Inc.
Mascoma Corporation
Massachusetts Biologic Laboratory
Massachusetts Biomedical Initiatives (MBI)
Massachusetts College of Pharmacy & Health Sciences
Massachusetts Institute of Technology
Massachusetts Office of International Trade and Investment
MassDevelopment
Matritech Inc.
Maxiom Group, Inc.
MaxThera, Inc.
MBL International
McDermott Will & Emery LLP
MedChem Partners
MedImmune, Inc.
Merck & Co., Inc.
Mercury Therapeutics, Inc.
Meredith & Grew, Inc.
Merrimack College
Merrimack Pharmaceuticals, Inc.
Mersana Therapeutics
Metabolix, Inc.
MGI PHARMA, Inc.
Microbia, Inc.
Microbiotix, Inc.
MicroCHIPS, Inc.
MicroTest Laboratories, Inc.
Millennium Pharmaceuticals, Inc.
Millipore Corporation
Minerva Biotechnologies Corp.
Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C.
Modular Genetics, Inc.
Molecular Insight Pharmaceuticals, Inc.
Momenta Pharmaceuticals, Inc.
Morse, Barnes- Brown & Pendleton, P.C.
Mount Auburn Hospital
Mouse Specifics, Inc.
MP Healthcare Venture
Management, Inc.
MPM Capital
MSM Protein Technologies
Murphy & McManus LLC
Mytogen, Inc.
NAI Hunneman Commercial Co.
Nanobiosym, Inc.
Nantero, Inc.
Neocure Group LLC
Netherlands Foreign Investment Agency
Neurogen Corp.
Neurotech USA, Inc.
New England Biolabs
New England Healthcare Institute
New England Peptide LLC.
New England Research Institutes, Inc.
NitroMed, Inc.
Nixon Peabody LLP
Northeastern University
Novartis Institutes for BioMedical Research, Inc.
NovoBiotic Pharmaceuticals
Nuclea Biomarkers LLC
NUCRYST Pharmaceuticals Corp.
Nutter, McClennen & Fish, LLP
OctoPlus
OmniGene Bioproducts, Inc.
One Cell Systems, Inc.
Ontario Ministry of Economic Development & Trade
ORBee Consulting
Organogenesis, Inc.
Organon Research Center USA
Oscient Pharmaceuticals
Osmetech, Inc.
Oxford Bioscience Partners
Oxford Finance Corporation
OXiGENE, Inc.
OxyPlus, Inc.
P.A. Technologies
P.P. Manufacturing Corporation
PA Consulting Group
Panacea Clinical Research
Panacea Discovery LLC
Panacos
Paratek Pharmaceuticals, Inc.
Parenteau BioConsultants, LLC
PAREXEL International Corp.
Partners Healthcare System, Inc.
PCI Synthesis
Peptimmune, Inc.
PERCIVIA LLC
Pericor Science Inc.
Pervasis Therapeutics, Inc.
Pfizer, Inc. Research Technology Center
PharmaMar USA Inc.
Pharmaplan North America, Inc.
PharmaPros Corporation
Phase Forward, Inc.
Phasex Corporation
Phillips, DiPisa & Associates
PHT Corporation
Phylonix
Pharmaceuticals, Inc.
Pioneer Valley Life Sciences Institute
Point Therapeutics Inc.
Polaris Venture Partners
PolyOrg, Inc.
PPD, Inc.
PRA International
Predictive Biosciences, Inc.
Pressure BioSciences, Inc.
Prestige Scientific
PricewaterhouseCoopers, LLP
Primera Biosystems
Prism Venture Partners
Pro-Pharmaceuticals, Inc.
Promedica CRC, Inc.
PROMETRIKA
Protein Forest, Inc.
Proteome Systems
Proteon Therapeutics, Inc.
Pulmatrix Inc.
QCB, Quality Control Biochemicals
Quantomix Inc.
Quebec Delegation
QuickSTAT - A division of
Quick International Courier
Radius (formerly Nuvios)
Randstad USA
Rapid Micro Biosystems, Inc.
Regis College
Regis Technologies
RenaMed Biologics
Repligen Corporation
Resolvyx Pharmaceuticals, Inc.
Rib-X Pharmaceutical, Inc.
RiboNovix, Inc.
Ricerca Biosciences, LLC
Ropes & Gray
Ross Systems
Russell Reynolds Associates
Sanofi Aventis Pharmaceuticals, Cambridge Genomics Center
SBH Sciences, Inc.
Schering-Plough Research Institute
Scimitar Equity Research, Inc.
Scottish Development International
Seahorse Bioscience
SelectX Pharmaceuticals, Inc.
Sepracor, Inc.
SeraCare Life Sciences, Inc.
Serica Technologies, Inc.
Shire Pharmaceuticals
Silicon Valley Bank
Sirtris Pharmaceuticals
SolMap Pharmaceuticals, Inc.
SouthCoast Development Partnership
Spherics, Inc.
StemCore
StratAcuity Scientific
Staffing, Inc.
Stryker Biotech
Suffolk University
Sullivan Insurance Group
Surface Logix, Inc.
Swiss House for Advanced Research and Education - Consulate of Switzerland
Syndexa Pharmaceuticals
Synomics Pharmaceutical Services
Synta Pharmaceuticals Corp.
T2 Biosystems
Targanta Therapeutics
TEI Biosciences, Inc.
Tempo Pharmaceuticals
Tepha, Inc
Tepnel LifeCodes Corporation
Teranode Corporation
Tessella Inc.
Tetraphase Pharmaceuticals, Inc.
TGA Sciences, Inc.
The Angiogenesis Foundation
The Forsyth Institute
The GI Company, Inc.
The Jackson Laboratory
The Richmond Group, Inc.
The Staubach Company of New England, LLC
Thermo Electron Corporation
Tobin & Sons Moving and Storage, Inc.
Tolerx Inc.
Total ReCord Inc.
Toxikon Corporation
Trammell Crow Company
TransForm Pharmaceuticals, Inc.
TransMolecular, Inc.
Transport Pharmaceuticals
Trine Pharmaceuticals, Inc.
Tsoi/ Kobus & Associates, Inc.
Tufts University, School of Veterinary Medicine: Cummings School
Turner Construction Company
Twining Properties
U.S. Genomics, Inc.
Unither Pharmaceuticals, Inc.
University of Connecticut Technology Incubation Program
University of Massachusetts
University of Massachusetts Medical School
Vaccine Technologies, Inc.
Verax Biomedical Incorporated
Vertex Pharmaceuticals, Inc.
ViaCell, Inc.
VICAM, L.P.
Vienna Business Agency
VisEn Medical
Whitehead Institute
William Gallagher Associates
Wilmer Cutler Pickering Hale and Dorr LLP
WMR Biomedical, Inc.
Wolf Greenfield & Sacks, PC
Wolfe Laboratories, Inc.
Wood MacKenzie Inc.
Worcester Polytechnic Institute
WorldCare
Wyeth Biotech and Wyeth Research Headquarters
Xanthus Pharmaceuticals, Inc.
Xceed Molecular
Xcellerex, Inc.
Xemplar Pharmaceuticals, LLC
ZIOPHARM, Inc.
ZymeQuest, Inc.

 
 
 
 
Cummings Properties LLC, 200 West Cummings Park, Woburn, MA 781-935-8000
 
Lease Boston, MA office space
Lease Boston, MA office space in the finest highway locations. Lease Massachusetts office and commercial space in 10 Massachusetts communities. Offering more than 8 million square feet of the finest office, R&D, laboratory and research space.


Lease Massachusetts office or R&D space
Lease Massachusetts office or R&D space in Boston, Cambridge, Woburn, Beverly, Medford, Somerville, Stoneham, Sudbury, Wakefield and Wilmington, MA. Offering more than 8 million square feet of prime office, laboratory, research and commercial space for lease in Massachusetts. Lease large or small Massachusetts medical office space, or any other commercial facilities.